Literature DB >> 2262364

Radioresponse of human astrocytic tumors across grade as a function of acute and chronic irradiation.

C J Schultz1, C R Geard.   

Abstract

Astrocytomas make up the largest group of primary brain tumors of glial origin. Long term survival is rare with high grade tumors (grades 3 and 4), which recur despite subtotal resection, chemotherapy, and aggressive postoperative radiation therapy. In contrast, the 5-year survival for low grade astrocytomas (grades 1 and 2) following subtotal resection and postoperative radiotherapy approaches 50%. Variable sensitivity across grade may contribute to the difference in the behavior of these tumors. To investigate this possibility, the radioresponse of human glial tumors across grade as a function of the dose rate of irradiation was studied. Cell lines derived from a low grade astrocytoma (grade 1) and two high grade astrocytomas (grades 3 and 4) were established in culture. Clonal survival was determined following irradiation of the three cell lines with Cesium 137 gamma rays at high dose rate, 78 Gy/hr, and at low dose rate, range 14 cGy to 79 cGy/hr. The low grade astrocytoma was found to be more radiosensitive than either of the high grade tumors. The alpha/beta (Gy-1/Gy-2) values (linear quadratic model) were 0.35/0.082 for the grade 1 line and 0.20/0.036 and 0.30/0.045 for the grade 3 and 4, respectively. D0 (cGy) values (single-hit multi-target model) were 99, 144, and 117 for grades 1, 3, and 4, respectively. A dose rate effect was present for all three tumor lines irradiated from 14 cGy/hr to 78 Gy/hr. An inverse dose rate effect was also noted at 37 cGy/hr for each of the astrocytic lines. These findings may be useful in the development of strategies to treat astrocytic brain tumors which use high and/or low dose rate irradiation.

Entities:  

Mesh:

Year:  1990        PMID: 2262364     DOI: 10.1016/0360-3016(90)90350-s

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Effects of interferon and PKC modulators on human glioma protein kinase C, cell proliferation, and cell cycle.

Authors:  M Acevedo-Duncan; R Zhang; D R Cooper; H M Greenberg
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

2.  Cell proliferative activity estimated by histone H2B mRNA level correlates with cytogenetic damage induced by radiation in human glioblastoma cell lines.

Authors:  Jerzy Slowinski; Urszula Mazurek; Grazyna Bierzynska-Macyszyn; Maria Widel; Malgorzata Latocha; Joanna Glogowska-Ligus; Monika Stomal; Ryszard Mrowka
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

Review 3.  Stereotactic radiosurgery and interstitial brachytherapy for glial neoplasms.

Authors:  M W McDermott; M S Berger; Sandeep Kunwar; Andrew T Parsa; P K Sneed; David A Larson
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

4.  The dosimetric enhancement of GRID profiles using an external collimator in pencil beam scanning proton therapy.

Authors:  Blake R Smith; Nicholas P Nelson; Theodore J Geoghegan; Kaustubh A Patwardhan; Patrick M Hill; Jen Yu; Alonso N Gutiérrez; Bryan G Allen; Daniel E Hyer
Journal:  Med Phys       Date:  2022-02-21       Impact factor: 4.071

5.  Pulsed reduced dose-rate radiotherapy: case report : a novel re-treatment strategy in the management of recurrent glioblastoma multiforme.

Authors:  George M Cannon; Wolfgang A Tomé; H Ian Robins; Steven P Howard
Journal:  J Neurooncol       Date:  2007-01-25       Impact factor: 4.506

6.  Clinical experience with planning, quality assurance, and delivery of burst-mode modulated arc therapy.

Authors:  Kristofer Kainz; Douglas Prah; Ergun Ahunbay; X Allen Li
Journal:  J Appl Clin Med Phys       Date:  2016-09-08       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.